相关实验视频
Updated: May 22, 2025

08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
940
斯塔波基巴特:第一次获得批准
1Springer Nature, Mairangi Bay, Private Bag 65901, Auckland, 0754, New Zealand. dru@adis.com.
Drugs
|March 17, 2025
概括
新型生物疗法Stapokibart在中国首次获得批准,用于治疗中度至重度的亚托皮炎. 这种介素-4受体α (IL-4Rα) 抑制剂向2型炎症通路,提供了一种新的治疗选择.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
背景情况:
- 亚托皮炎是一种慢性炎症性皮肤疾病.
- 2型细胞因子,包括IL-4和IL-13,在亚托皮性皮炎的发病过程中起着关键作用.
- 准IL-4受体α (IL-4Rα) 子单元提供了一个潜在的治疗策略.
研究的目的:
- 为了总结Stapokibart的发展里程碑.
- 为了突出第一个监管批准的stapokibart对亚托皮性皮肤炎.
- 提供Stapokibart的作用机制和治疗潜力的概述.
主要方法:
- 开发了stapokibart,一种人性化的IgG4单克隆抗体.
- 准介素-4受体α (IL-4Rα) 子单元.
- 阻断IL-4和IL-13的信号通路.
主要成果:
- 斯泰波基巴特于2024年9月在中国首次获得批准,用于中度至重度的亚托邦性皮肤炎.
- 随后在中国批准的药物包括带有鼻息肉的慢性鼻炎和季节性过敏性鼻炎.
- 斯塔波基巴特正在临床评估喘,慢性肺炎和结节炎.
结论:
- 斯塔波基巴特在治疗2型炎症性疾病方面取得了重大进展.
- 批准标志着KeyMed生物科学和阿托皮性皮肤炎患者的关键里程碑.
- 进一步的临床评估正在进行中,以扩大stapokibart的治疗应用.
相关概念视频
Drug Metabolism: Phase I Reactions
2.9K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
2.9K
Drug Administration and Therapy Phases: Overview
401
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
401
First Pass Effect
4.9K
Presystemic elimination, or the first-pass effect, is the metabolism of drugs that reduces their effective concentration at the site of action. Apart from the first-pass effect, the systemic bioavailability of the drug is also reduced by other factors, including incomplete absorption or chemical degradation of drugs.
Depending on the route of administration, drugs can be metabolized in the liver, intestine, lungs, and vasculature. Orally administered drugs are first absorbed through the...
Depending on the route of administration, drugs can be metabolized in the liver, intestine, lungs, and vasculature. Orally administered drugs are first absorbed through the...
4.9K
Factors Influencing Bioavailability: First-Pass Elimination
6.0K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
6.0K
Depolarizing Blockers: Pharmocokinetics
299
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
299
Drug Metabolism: Phase II Reactions
3.5K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.5K

